CD1d Antikörper
Kurzübersicht für CD1d Antikörper (ABIN7814091)
Target
Alle CD1d (CD1D) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse CD1d Monoclonal Antibody
-
Produktmerkmale
- IgG2b
-
Isotyp
- IgG2b
-
-
anti-CD1d Molecule (CD1D) (AA 56-271) antibody
CD1D Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-CD1d Molecule (CD1D) (AA 32-302) antibodyCD1D Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-CD1d Molecule (CD1D) (AA 20-190) antibodyCD1D Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-CD1d Molecule (CD1D) antibody (PE)CD1D Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal 51-1 PE
anti-CD1d Molecule (CD1D) antibodyCD1D Reaktivität: Maus, Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-CD1d Molecule (CD1D) antibodyCD1D Reaktivität: Human, Non-Human Primate FACS, WB, IP, IHC (fro) Wirt: Maus Monoclonal 51-1 unconjugated
anti-CD1d Molecule (CD1D) antibodyCD1D Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-CD1d Molecule (CD1D) (AA 177-206) antibodyCD1D Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB36769 unconjugated
anti-CD1d Molecule (CD1D) (Internal Region) antibodyCD1D Reaktivität: Maus, Human, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-CD1d Molecule (CD1D) (AA 1-335) antibodyCD1D Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4.
-
Handhabung
- Avoid repeated freeze-thaw cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles
-
Haltbarkeit
- 12 months
-
-
- CD1d (CD1D) (CD1d Molecule (CD1D))
-
Andere Bezeichnung
- CD1d
-
Hintergrund
- Anti-CD1D, Anti-R3G1
-
UniProt
- P11609, P11610
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-
